• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Isolagen reports progress in nasolabial-fold therapy trials

Exton, Pa. - Biotech company Isolagen announced recently that injections have been completed in the phase 3 clinical trials evaluating the Isolagen Therapy for the treatment of nasolabial folds, and that trial subjects are now in the follow-up period, PRNewswire reports.

Exton, Pa. - Biotech company Isolagen announced recently that injections have been completed in the phase 3 clinical trials evaluating the Isolagen Therapy for the treatment of nasolabial folds, and that trial subjects are now in the follow-up period, PRNewswire reports.

Isolagen also announced the completion of injections in the phase 2 open-label study, which is gathering further safety and application information on the use of the Isolagen Therapy.

Related Videos
E. James Song is featured in this video series.
E. James Song is featured in this video series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
E. James Song is featured in this video series.
E. James Song is featured in this video series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.